| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Pulled from Benzinga Pro data EXFO (NASDAQ:EXFO) showed a loss in earnings since Q2, totaling $3.66 million. Sales, on the other hand, increased by 4.9% to $72.64 million during Q3. In Q2, EXFO earned $3.76 million and total sales reached $69.25 million.
Changes in earnings and sales indicate shifts in EXFO's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, EXFO posted an ROCE of 0.02%.
It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.
ROCE is an important metric for the comparison of similar companies. A relatively high ROCE shows EXFO is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and earnings per share growth.
In EXFO's case, the positive ROCE ratio will be something investors pay attention to before making long-term financial decisions.
EXFO reported Q3 earnings per share at $-0.07/share, which did not meet analyst predictions of $0.03/share.
Posted In: EXFO
